Literature DB >> 15172758

Parental 19q loss and PEG3 expression in oligodendrogliomas.

Oriane Trouillard1, Lucinda Aguirre-Cruz, Khe Hoang-Xuan, Yannick Marie, Jean-Yves Delattre, Marc Sanson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15172758     DOI： 10.1016/j.cancergencyto.2003.09.021

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN： 0165-4608


× No keyword cloud information.
  4 in total

Review 1.  Molecular profiling of oligodendrogliomas: impact on prognosis, treatment, and future directions.

Authors:  Douglas E Ney; Andrew B Lassman
Journal:  Curr Oncol Rep       Date:  2009-01       Impact factor: 5.075

Review 2.  Molecular neuropathology of gliomas.

Authors:  Markus J Riemenschneider; Guido Reifenberger
Journal:  Int J Mol Sci       Date:  2009-01-07       Impact factor: 6.208

3.  Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses.

Authors:  Artemis P Vogazianou; Raymond Chan; L Magnus Bäcklund; Danita M Pearson; Lu Liu; Cordelia F Langford; Simon G Gregory; V Peter Collins; Koichi Ichimura
Journal:  Neuro Oncol       Date:  2010-02-17       Impact factor: 12.300

4.  Aberrant promoter methylation and expression of the imprinted PEG3 gene in glioma.

Authors:  Susumu Otsuka; Shinji Maegawa; Ayumi Takamura; Hideki Kamitani; Takashi Watanabe; Mitsuo Oshimura; Eiji Nanba
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2009       Impact factor: 3.493
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.